What Vaxa does

Vaxa Inc. is a privately held, boutique strategy consulting firm headquartered in Hollywood, Florida, founded in 1998 by Steven Nathasingh. The firm focuses exclusively on revenue growth strategy and GTM execution for enterprise clients, organized around four core service lines: Growth Strategy, Vaxa Implementation, Customer Strategy, and Research & Intelligence. Its service offering is reinforced by proprietary reference assets, including healthcare databases covering 180,000+ clinical trials, 6,500+ hospitals, and 750,000+ physician offices, alongside a channel partner database, competitive intelligence, and a MegaTrends analysis framework.

Vaxa's business model is sales-led, direct-engagement advisory work priced on project basis with senior partners, supported by case-study evidence of Fortune 25, Fortune 50, and Fortune 20 client engagements across technology, banking, software, and consumer packaged goods. The firm claims over 15 years of results, including $250B+ in growth opportunities generated and a $2B incremental revenue outcome for a Fortune 20 technology client, alongside stated global delivery across the Americas, Europe, and Asia-Pacific. Senior talent carries pedigree from AT Kearney, Roche, Wyeth, Merrill Lynch, and Northwestern, and the firm is currently sized at 11-50 employees.

Go-to-market is relationship-driven rather than productized, with no public funding rounds, no parent entity, and limited public visibility. Supporting commercial signals include partnerships with a Fortune 50 IT company's pharmaceutical ecosystem, the TrackInc. wearable startup for clinical trials GTM, and social-impact initiatives such as the National Multiple Sclerosis Society. Operational scale remains constrained by headcount, and revenue, growth rate, and customer concentration are not publicly disclosed.

Name

Vaxa

Legal name

Vaxa Inc.

Website

https://vaxainc.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Management Consulting

NAICS

Management Consulting Services (54161), Marketing Consulting Services (541613)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Customer Experience (CX) & Voice-of-Customer Analytics (BPAHALAK)

akta.pro secondary industries

B2B / Account-Based Marketing (ABM) Strategy Consulting (MPAAAFAM), Customer Experience (CX) & Digital Experience (BPAHAEAC)

Keywords

• Strategy consulting
• Growth strategy
• Market research
• Customer strategy
• Competitive intelligence

Headquarters

HQ city

Hollywood

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Strategy Consulting Services: Vaxa generates revenue through consulting engagements focused on growth strategy, customer strategy, market research, and implementation. They work with leading companies to identify new market opportunities and increase share-of-wallet with existing customers. Revenue is generated through project-based consulting fees.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Vaxa Inc. is a strategy consulting firm that delivers custom engagements to help leading enterprises identify and enter new markets and increase share-of-wallet with existing customers. Their services span Growth Strategy (including MegaTrends analysis, innovation in strategy, emerging and growth markets, venturing and incubation, and monetizing technologies), Vaxa Implementation, Customer Strategy (channels design and optimization, customer insights, dynamic segmentation, pricing), and Research & Intelligence (channel partners and alliances, Horizons research, competitive intelligence, and data services). They serve Fortune-tier enterprise clients with executive-level sponsors across North America, Europe, and Asia-Pacific.

Product overview

Vaxa Inc. is a strategy consulting firm offering a portfolio of consulting services rather than a unified software product. The core offering consists of consulting engagements across Growth Strategy, Customer Strategy, Vaxa Implementation, and Research & Intelligence. Supporting these are proprietary databases covering healthcare (clinical trials, hospitals, physician offices), channel partners, and competitive intelligence. The firm provides thought leadership through its Vaxa Insights publications covering topics such as wearables, biosensors, and MegaTrends analysis.

Differentiator

Problem solved

Functional benefit

Products and services

• Growth Strategy Consulting Strategy consulting engagements encompassing MegaTrends to Opportunities, Growing Marketshare, Innovation in Strategy, Emerging and Growth Markets, Venturing and Incubation, and Monetizing Technologies. Designed for General Managers, Corporate Strategy teams, and Business Unit leaders at large enterprises seeking to identify and enter new markets and create lasting revenue growth.
• Vaxa Implementation Hands-on implementation support to bridge from strategic insight to execution. Designed for enterprise clients who need assistance translating growth strategy recommendations into operational outcomes and sustained business results.
• Customer Strategy Consulting Customer strategy engagements covering Channels Design and Optimization, Customer Insights, Dynamic Segmentation, and Pricing. Targeted at Sales and Marketing executives, Channels teams, Product Management, Alliances, Branding, and Pricing functions seeking to increase share-of-wallet with existing customers.
• Research and Intelligence Research and intelligence services including Channel Partners and Alliances, Horizons research, Competitive Intelligence, and Data Services. Provides fact-based insights and unbiased perspectives for Marketing Research and Intelligence teams and enterprise clients seeking deep market understanding.

Quantifiable outcome

• Over $250B in growth opportunities generated for clients
• +6 more outcomes

Named customers3 records

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered minor and core.

• National Multiple Sclerosis SocietyminorStrategic or Co-development Partner · 1 January 2016Vaxa is working with the National Multiple Sclerosis Society and their South Florida division to raise awareness of Multiple Sclerosis, a debilitating neurological disease. Vaxa is assisting with strategy and implementation of the 2016 walk-a-thon to raise funds and awareness. Steven Nathasingh co-presented with Dr. Ray Dorsey MD of University of Rochester at Scope 2016 on use of wearable sensors in neurology clinical studies.
• Multiple Sclerosis Society of South FloridaminorStrategic or Co-development PartnerVaxa is working with Multiple Sclerosis Society of South Florida assisting with their strategy and implementation of the 2016 walk to raise funds and awareness of the disease. Vaxa team participated in one of six walks and made donations.
• Boy Scouts of AmericaminorStrategic or Co-development PartnerVaxa works with not-for-profit organizations including Boy Scouts of America, lending their for-profit expertise to advance social impact of organizations.
• Local Homeless SheltersminorStrategic or Co-development PartnerVaxa works with local homeless shelters as part of their community giving-back initiatives, applying their expertise to help these organizations.
• Healthcare Providers and Care GiversminorStrategic or Co-development PartnerVaxa works with wearable companies who want to understand today's healthcare ecosystem for mobile technologies, and with care providers to develop mobility strategies. They analyze how wearables can contribute to healthcare outcomes valued by individuals and healthcare providers.
• Global Pharmaceutical EcosystemcoreStrategic or Co-development PartnerVaxa worked with a Fortune 50 IT company to engage the global pharmaceutical ecosystem to understand and predict how the human genome will change drug research and development. This involved creating strategic alignment between different business units and predicted solutions.
• Clinical Research OrganizationsminorStrategic or Co-development PartnerVaxa assisted a wearables startup (TrackInc.) to design go-to-market strategy for clinical trials. This included identifying product development priorities, portfolio of alliance partners who contribute technical expertise and business development, research and academic partnerships to prove out technology efficacy.
• Research and Academic InstitutionsminorStrategic or Co-development PartnerVaxa helped identify research and academic partnerships that will prove out technology efficacy for wearables in clinical trials. Embedded activity tracker products into specific clinical trials in US, Germany, Italy, and China.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• L.E.K. Consulting: Global boutique strategy consulting firm of similar size and orientation, focused on growth strategy, commercial due diligence, and life sciences work. Directly comparable in service mix and client profile to Vaxa.
• Putnam Associates: Specialized boutique strategy consulting firm serving the life sciences industry on commercial strategy, pricing, and market access. Highly comparable to Vaxa's healthcare and pharma vertical focus.
• ZS Associates: Global consulting firm specializing in pharmaceuticals, healthcare, and technology-driven commercial strategy. Comparable to Vaxa in pharma/tech crossover engagements and analytical methodology.
• Simon-Kucher & Partners: Boutique consulting firm globally recognized for pricing, growth strategy, and commercial excellence. Closely comparable to Vaxa's growth strategy and pricing service lines.

Broad incumbents

• AT Kearney: Major global strategy and management consulting firm where Vaxa's founder previously served as Director. Comparable in growth strategy offerings but materially larger and broader in scope.
• Roland Berger: Global strategy consulting firm headquartered in Europe with strong European industrial and technology practice. Comparable strategic offerings to Vaxa but at substantially larger scale.
• McKinsey & Company: Largest global management consulting firm, offers growth strategy and customer strategy practices that directly overlap Vaxa's core service lines but at much broader scale and with preferred-vendor positioning.
• Bain & Company: Global strategy consulting firm with comparable growth strategy, customer strategy, and pricing capabilities. Competes with Vaxa for large enterprise strategy mandates across industries.
• Boston Consulting Group: Global strategy consulting leader with adjacent growth strategy, technology, and healthcare industry practices. Overlaps with Vaxa's strategic offering but at enterprise scale.
• Oliver Wyman: Global management consulting firm with strategy, operations, and risk practices serving financial services, healthcare, and industrial clients. Overlaps Vaxa's growth and customer strategy work for large enterprises.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/vaxainc
• Facebookfacebook.com/vaxainc
• LinkedInlinkedin.com/company/vaxa-inc.

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vaxa